Hope Biosciences launches stem cell trial for children with arthritis (Juvenile Rheumatoid/Idiopathic Arthritis)

Statement:

Hope Biosciences has received FDA clearance for a clinical trial where they will extract fat from the children, process it to isolate the stem cells, and do an IV infusion to see if it helps children with idiopathic arthritis.

The Phase II clinical trial (NCT06623240) is being conducted by Hope Biosciences Research Foundation (HBRF) at their Sugar Land, Texas site and is currently enrolling participants. The company says the trial will use a balanced, randomized, double-blind, crossover design, involving an 8-week active treatment period with three infusions, followed by a 12-week period without treatment, and then another 8-week period with three more treatments.